Skip to main content
Figure 2 | Proteome Science

Figure 2

From: Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Figure 2

Different relative intensities of three peptide peaks between AML newly diagnosed group and healthy control group. (A) Upregulated of the peptide with MW of 3216.57 Da in AML newly diagnosed group. (B) Down regulated of the peptide with MW of 4089.7 Da in AML newly diagnosed group. (C) Down regulated of the peptide with MW of 7762.87 Da in AML newly diagnosed group. (Red: AML newly diagnosed group Green: Healthy control group).

Back to article page

Proteome Science

ISSN: 1477-5956